Polypharmacy in HIV: Rethinking what counts and why it matters
HIV Medicine, EarlyView.Abstract Polypharmacy, the concurrent use of multiple medications, presents a growing challenge in HIV care as people living with HIV age and experience earlier onset of age‐related co‐morbidities. However, how polypharmacy is defined and assessed in HIV research remains inconsistent.
Luxsena Sukumaran +6 more
wiley +1 more source
Barriers to antiretroviral therapy adherence in developed countries: a qualitative synthesis to develop a conceptual framework for a new patient-reported outcome measure [PDF]
, 2018 Kim Engler +4 more
openalex +1 more source
Temporal network analysis of comorbidities among people with HIV in South Carolina
HIV Medicine, EarlyView.Abstract Introduction People with HIV experience a high rate of comorbidities that can complicate their health outcomes. Understanding the prevalence, interrelationships and temporal development of these comorbidities is crucial for improving health management and quality of life for people with HIV.
Yunqing Ma +6 more
wiley +1 more source
Atherosclerosis PlusBackground: Atherosclerotic cardiovascular disease (ASCVD) is a leading cause of morbidity and mortality in HIV patients, but the impact of combined antiretroviral therapy regimens on its risk in Ethiopia is unclear. This study assessed the 10-year ASCVD
Balew Arega +6 more
doaj +1 more source
Intensifying Antiretroviral Therapy With Raltegravir and Maraviroc During Early Human Immunodeficiency Virus (HIV) Infection Does Not Accelerate HIV Reservoir Reduction [PDF]
, 2015 Mario Ostrowski +11 more
openalex +1 more source
HIV Medicine, EarlyView.Abstract Objective Prevalence of geriatric syndromes including frailty among people living with HIV is increasing and at younger ages. There is no gold standard model of care for people with HIV and frailty. This study aimed to determine the acceptability of a comprehensive geriatric assessment and management plan, delivered jointly by a geriatrician ...
Natalie St Clair‐Sullivan +10 more
wiley +1 more source
Changes in Inflammation but Not in T-Cell Activation Precede Non-AIDS-Defining Events in a Case-Control Study of Patients on Long-term Antiretroviral Therapy [PDF]
, 2017 Konstantia Angelidou +7 more
openalex +1 more source
HIV Medicine, EarlyView.Abstract Objectives The gp120‐directed attachment inhibitor fostemsavir was effective in people with multidrug‐resistant (MDR) HIV‐1 in the BRIGHTE study. Understanding factors associated with virologic response can help clinicians optimize treatment and identify individuals for fostemsavir‐based regimens.
M. Gartland +8 more
wiley +1 more source
Factors Affecting the Success Therapy of Antiretroviral in People with HIV/AIDS in Prof. Dr. W.Z. Johannes Hospital, Kupang, East Nusa Tenggara [PDF]
, 2018 Background: HIV/AIDS is an important public health problem in the world including Indonesia. People living with HIV/AIDS (PLWHA) who are not on antiretroviral therapy for more than 3 months will have an impact on increased opportunistic infections and ...
Boro, T. L. (Thomas) +2 more
core